Bruno Daniele

Summary

Affiliation: G. Rummo Hospital
Country: Italy

Publications

  1. ncbi request reprint Staging for liver cancer
    Bruno Daniele
    Medical Oncology Unit, G Rummo Hospital, Benevento, Italy
    Clin Liver Dis 9:213-23, vi. 2005
  2. pmc Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma
    Ciro Gallo
    Department of Medicine and Public Health, Second University, Naples, Italy
    BMC Cancer 6:196. 2006
  3. ncbi request reprint Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma
    Bruno Daniele
    Medical Oncology Unit, G Rummo Hospital, Via dell Angelo 1, 82100 Benevento, Italy
    Gastroenterology 127:S108-12. 2004
  4. pmc Right-sided rhabdoid colorectal tumors might be related to the serrated pathway
    Massimo Pancione
    Department of Biological, Geological and Environmental Sciences, University of Sannio, Benevento, Italy
    Diagn Pathol 8:31. 2013
  5. doi request reprint A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation
    Massimo Pancione
    Department of Biological and Environmental Sciences, University of Sannio, 82100 Benevento, Italy
    Hum Pathol 42:1047-52. 2011
  6. doi request reprint Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer
    Massimo Pancione
    Department of Biological and Environmental Sciences, University of Sannio, 82100 Benevento, Italy
    Hum Pathol 41:867-76. 2010
  7. ncbi request reprint Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma
    Bruno Daniele
    Oncology Unit, G Rummo Hospital, Benevento, Italy
    Hepatol Res 37:S206-9. 2007
  8. doi request reprint Re: Design and endpoints of clinical trials in hepatocellular carcinoma
    Massimo Di Maio
    J Natl Cancer Inst 100:1557; author reply 1557-8. 2008
  9. ncbi request reprint [Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography]
    Emiddio Barletta
    Recenti Prog Med 96:295-9; quiz 328. 2005
  10. pmc Is human hepatocellular carcinoma a hormone-responsive tumor?
    Massimo Di Maio
    Medical Oncology, N Giannettasio Hospital, Rossano 87068, Italy
    World J Gastroenterol 14:1682-9. 2008

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Staging for liver cancer
    Bruno Daniele
    Medical Oncology Unit, G Rummo Hospital, Benevento, Italy
    Clin Liver Dis 9:213-23, vi. 2005
    ..The peculiarity of hepatocellular carcinoma patients are addressed, and each individual prognostic systems for hepatocellular carcinoma is presented and discussed...
  2. pmc Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma
    Ciro Gallo
    Department of Medicine and Public Health, Second University, Naples, Italy
    BMC Cancer 6:196. 2006
    ..However, a recent report suggested that the drug might prolong survival among patients with well preserved liver function. The aim of this paper is to validate this hypothesis...
  3. ncbi request reprint Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma
    Bruno Daniele
    Medical Oncology Unit, G Rummo Hospital, Via dell Angelo 1, 82100 Benevento, Italy
    Gastroenterology 127:S108-12. 2004
    ..US seems more efficient as a screening tool. Pathology assessment of liver explants in living-donor transplantation programs will provide more precise and reliable information regarding the value of AFP and US as HCC screening tools...
  4. pmc Right-sided rhabdoid colorectal tumors might be related to the serrated pathway
    Massimo Pancione
    Department of Biological, Geological and Environmental Sciences, University of Sannio, Benevento, Italy
    Diagn Pathol 8:31. 2013
    ..The differential diagnosis is with the malignant rhabdoid tumors of infancy characterized by genetic inactivation of SMARCB1 (INI1) or deletions of chromosome 22q12 locus...
  5. doi request reprint A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation
    Massimo Pancione
    Department of Biological and Environmental Sciences, University of Sannio, 82100 Benevento, Italy
    Hum Pathol 42:1047-52. 2011
    ..This is the first case of a colorectal carcinoma with rhabdoid features, "CpG island methylator phenotype," high microsatellite instability associated with a BRAF mutation, and patient poorer outcome...
  6. doi request reprint Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer
    Massimo Pancione
    Department of Biological and Environmental Sciences, University of Sannio, 82100 Benevento, Italy
    Hum Pathol 41:867-76. 2010
    ..We suggest that a combination of low beta-catenin and high p53 expression in primary colorectal cancers may be a prognostic factor in predicting the progression of the disease, the occurrence of metastasis, and a more severe outcome...
  7. ncbi request reprint Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma
    Bruno Daniele
    Oncology Unit, G Rummo Hospital, Benevento, Italy
    Hepatol Res 37:S206-9. 2007
    ..Conclusions: The CLIP score keeps good prognostic and discriminative abilities after a longer follow up and remains one the most useful prognostic system for hepatocellular carcinoma...
  8. doi request reprint Re: Design and endpoints of clinical trials in hepatocellular carcinoma
    Massimo Di Maio
    J Natl Cancer Inst 100:1557; author reply 1557-8. 2008
  9. ncbi request reprint [Screening of hepatocellular carcinoma: role of the alpha-fetoprotein (AFP) and ultrasonography]
    Emiddio Barletta
    Recenti Prog Med 96:295-9; quiz 328. 2005
    ..Pathology assessment of liver explants in living donor transplantation programs will provide more precise and reliable information regarding the value of AFP and ultrasonography as HCC screening tools...
  10. pmc Is human hepatocellular carcinoma a hormone-responsive tumor?
    Massimo Di Maio
    Medical Oncology, N Giannettasio Hospital, Rossano 87068, Italy
    World J Gastroenterol 14:1682-9. 2008
    ..Negative results have been obtained also with anti-androgen therapy. In conclusion, there is no robust evidence to consider HCC a hormone-responsive tumor. Hormonal treatments should not be part of the current management of HCC...
  11. ncbi request reprint Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)
    Sandro Pignata
    Oncologia Medica B, Istituto Nazionale per lo Studio e la Cura dei Tumori, Napoli, Italy
    Crit Rev Oncol Hematol 59:243-9. 2006
    ..To describe the characteristics at presentation and the outcome of elderly patients (> or =70 years old) with HCC, a retrospective analysis using a CLIP database was performed...
  12. ncbi request reprint Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients
    Alessandro Ottaiano
    Department of Clinical Immunology, National Cancer Institute, G Pascale Foundation, Naples, Italy
    Clin Cancer Res 12:2795-803. 2006
    ....
  13. pmc Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients
    Steven A Curley
    Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4095, USA
    Ann Surg 239:450-8. 2004
    ..We performed this prospective analysis to determine early (within 30 days) and late (more than 30 days after) complication rates associated with hepatic tumor RFA...
  14. ncbi request reprint Transcatheter arterial procedures in the treatment of patients with hepatocellular carcinoma: a review of literature
    Ermelinda De Maio
    Medical Oncology B, National Cancer Institute of Naples, Via M Semmola, 80131, Naples, Italy
    Crit Rev Oncol Hematol 46:285-95. 2003
    ....
  15. ncbi request reprint Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer
    Courtney L Scaife
    Departments of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Surg Oncol 10:348-54. 2003
    ..We conducted a study to determine the feasibility of using HAI after RFA for colorectal cancer (CRC) liver metastases...
  16. ncbi request reprint Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study
    Bruno Daniele
    Oncologia Medica B, Oncologia Chirurgica CM, Istituto Nazionale Tumori, Napoli, Italy
    J Clin Gastroenterol 36:63-7. 2003
    ..Patients with small hepatocellular carcinoma (HCC) are usually treated with hepatic resection or percutaneous ethanol injection (PEI)...
  17. ncbi request reprint Hepatocellular carcinoma: systemic treatments
    Massimo Di Maio
    Medical Oncology, National Cancer Institute, Naples, Italy
    J Clin Gastroenterol 35:S109-14. 2002
    ..In the future, innovative and promising therapeutic strategies will be tested in HCC, including new biologic target-based drugs, cyclooxygenase inhibitors, and gene therapy...
  18. ncbi request reprint Clinical features, etiology, and survival of hepatocellular carcinoma among different countries
    Masao Omata
    Department of Gastroenterology, University of Tokyo Graduate School of Medicine, Japan
    J Gastroenterol Hepatol 17:S40-9. 2002